Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.

Meta-analysis of Cyclooxygenase-2 Inhibitors and Their Effects on Blood Pressure

Tai‐Juan Aw, Steven Joseph Haas, Danny Liew, Henry Krum · 2005 · Archives of Internal Medicine

Abstract

Background Nonselective nonsteroidal anti-inflammatory drugs (NSAIDs) are widely prescribed and are associated with blood pressure (BP) elevation. The development of selective cyclooxygenase-2 inhibitors (coxibs) raises the issue of the magnitude of BP response compared with nonselective NSAIDs. We therefore performed a meta-analysis comparing the effects of coxibs with placebo, nonselective NSAIDs, and each other on BP elevation and hypertension. Methods Nineteen randomized controlled trials involving coxibs were published before May 2004, with a total of 45 451 participants in which BP data were available. The Cohen method statistically combined weighted mean difference (WMD). The Der Simonian and Laird method pooled results concerning the relative risk (RR) of developing hypertension and the RR of clinically important BP elevations. Results Among the trials analyzed, coxibs caused a WMD point estimate increase in systolic and diastolic BP compared with placebo (3.85/1.06 mm Hg) and nonselective NSAIDs (2.83/1.34 mm Hg). Cyclooxygenase-2 inhibitors were associated with a nonsignificantly higher RR of causing hypertension compared with placebo (RR, 1.61; 95% confidence interval [CI], 0.91-2.84; P = .10) and nonselective NSAIDs (RR, 1.25; 95% CI, 0.87-1.78; P = .23). Rofecoxib induced a WMD point estimate increase in systolic BP (2.83 mm Hg) and a nonsignificantly higher risk of developing clinically important systolic BP elevation (RR, 1.50; 95% CI, 1.00-2.26; P = .05) compa…

Overview

Integrity signals

Registry

Crossref · 10.1001/archinte.165.5.ioi50013

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 40 references

Cited by

See all 329

Metadata

Authors
Aw, T., Haas, S. J., Liew, D., & Krum, H.
Affiliations
The Alfred Hospital (AU)
Venue
Archives of Internal Medicine
Published
2005-03-14
Volume
165
Issue
5
Pages
490
ISSN
0003-9926 (ISSN-L)
OpenAlex
W1780627874
Cited by
329
References
40
Citations by year
2026: 2 · 2025: 3 · 2024: 3 · 2023: 6 · 2022: 6 · 2021: 6 · 2020: 13 · 2019: 8 · 2018: 15 · 2017: 8 · 2016: 16 · 2015: 10 · 2014: 20 · 2013: 11 · 2012: 16
FWCI
4.33
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
Keywords
COX-2 inhibitors, elevated blood pressure, hypertension, non-selective NSAIDs, rofecoxib, celecoxib, cardiovascular risk, drug-induced hypertension
MeSH terms
Anti-Inflammatory Agents, Non-Steroidal, Blood Pressure, Female, Humans, Male, Risk, Confidence Intervals, Randomized Controlled Trials as Topic, Cyclooxygenase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Meta-analysis of Cyclooxygenase-2 Inhibitors and Their Effects on Blood Pressure. https://app.cochat.ai/papers/10.1001/archinte.165.5.ioi50013
The paper
Aw, T., Haas, S. J., Liew, D., & Krum, H. (2005). Meta-analysis of Cyclooxygenase-2 Inhibitors and Their Effects on Blood Pressure. Archives of Internal Medicine. https://doi.org/10.1001/archinte.165.5.ioi50013

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.